What is the earliest age for using sclerosing agents for the management of a cervicofacial lymphangioma leading to remodelation of maxillfacial bones? In other words is it possible to use any kind of sclerosing agent for the management of a cervicofacial macrocystic lymphangioma causing rapid remodelation of maxillofacial bones in a newborn?
In complex cases in which they can compromise life, aesthetics or function, as soon as you can with agents like ok 432 for example, even in the neonatal period. Its efficacy and safety have been demonstrated even before the prenatal period.
We are using Injection bleomycin in neonates for cervicofacial lymphangioma without complication in our setup. Earliest age was 10 days.
I agree with the other two contributors. Earlier than one month after birth. We use Minocin more frequently.
- Badges
- Science topic
- Similar topics
- Philosophy
- Philosophy Of Science
- Reasoning